Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

immunization

- PMLiVE

Afon Technology’s glucose monitoring device secures Junkosha award plus $25,000 prize

The company was presented with the award in recognition of its Glucowear device

- PMLiVE

Budget burnout: avoiding the pitfalls of outdated engagement strategies

By Jake Crute

- PMLiVE

Fox&Cat relaunches with industry-first efficiency and effectiveness planning framework ADAPT

ADAPT was created alongside in-house teams, a behaviour change expert and a well-being coach

- PMLiVE

Navigating the future of AI: Insights from EphMRA’s one day meeting in London

Authored by: Ellie Forde and Mark Braund, Directors

Inizio

- PMLiVE

Ipsen and Skyhawk announce $1.8bn partnership to advance rare neurological disease therapies

The agreement gives Ipsen an option to receive exclusive global rights to two candidates

- PMLiVE

NICE recommends Menarini’s Nexpovio combination to treat multiple myeloma

More than 4,500 new patients are diagnosed with this form of blood cancer every year in the UK

- PMLiVE

World Health Organization prequalifies simplified oral cholera vaccine Euvichol-S

The acute diarrhoeal illness was reported to affect around 473,000 people in 2022

- PMLiVE

Cerevel Therapeutics shares positive phase 3 results for tavapadon in Parkinson’s disease

The progressive neurodegenerative disease affects seven million people worldwide

- PMLiVE

Uncovering the millennial mindset – why two thirds of HCPs feel misunderstood by pharma

By Phil Streit

- PMLiVE

Roche’s ALK inhibitor Alecensa receives FDA approval to treat early-stage NSCLC

Approximately half of all patients with early lung cancer experience cancer recurrence following surgery

- PMLiVE

Ipsen announces launch of new UK headquarters in London life sciences community

The Paddington site will serve as one of the company’s three global hubs

- PMLiVE

GSK’s shingles vaccine shown to maintain high protection in long-term study

The infectious condition affects up to one in three people globally in their lifetimes

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links